Allopurinol
Product Images NDC 50090-1867

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Allopurinol (NDC 50090-1867). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Allopurinol Structural Formula (Image 1)

FDA Label Image

Allopurinol Is A Structural Analogue Of The Natural Purine Base, Hypoxanthine. It Is An Inhibitor Of Xanthine Oxidase, The Enzyme Responsible For The Conversion Of Hypoxanthine To Xanthine And Of Xanthine To Uric Acid, The End Product Of Purine Metabolism In Man. Allopurinol Is Metabolized To The Corresponding Xanthine Analogue, Oxipurinol (alloxanthine), Which Also Is An Inhibitor Of Xanthine Oxidase. (Image 2)

This appears to be a list of chemical compounds including Allopurinol and Oxipurinol, as well as Xanthine, Uric Acid, Hypoxanthine, and Purine derivatives with corresponding chemical structures.*

FDA Label Image

Label Image (Lbl500901867)

FDA Label Image

Label Image (Lbl500902544)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.